Swe TM, Johnson DC, Mar HT, Thit P, Homan T, et al.
2023-02-17 • Health Science Reports
2023-02-17 • Health Science Reports
BACKGROUND AND AIMS In Myanmar, public sector treatment programs for hepatitis C virus (HCV) infection were nonexistent until June 2017. WHO highlights the importance of simplificati...
Ousley J, Soe KT, Kyaw NTT, Anicete R, Mon PE, et al.
2018-03-21 • Public Health Action
2018-03-21 • Public Health Action
Setting: A southern Myanmar district providing isoniazid preventive therapy (IPT) in one of the last countries to formally recommend it as part of human immunodeficiency virus (HIV) care...
Murray J, Whitehouse K, Ousley J, Bermudez E, Soe TT, et al.
2020-03-20 • BMC Infectious Diseases
2020-03-20 • BMC Infectious Diseases
BACKGROUND:
Adolescents living with HIV/AIDS (ALHIV) are a particularly vulnerable but often overlooked group in the HIV response despite additional disease management challenges.
<...
Ousley J, Nesbitt RC, Kyaw NTT, Bermudez E, Soe KT, et al.
2018-12-14 • BMC Infectious Diseases
2018-12-14 • BMC Infectious Diseases
BACKGROUND In Southeast Asia, though fishermen are known to be a key population at high risk of HIV, little is known about their co-infection rates with Hepatitis C virus (HCV), or h...
Bermudez-Aza EH, Shetty S, Ousley J, Kyaw NTT, Soe TT, et al.
2018-02-08 • PLOS One
2018-02-08 • PLOS One
OBJECTIVE To study the long-term clinical, immunological and virological outcomes among people living with HIV on antiretroviral therapy (ART) in Myanmar.
